Impaired glucose tolerance and heterogeneity of insulin responses in cows with abomasal displacement

Metabolic responses of lactating dairy cows to single and multiple subcutaneous injections of glucagon

Continuous, intravenous infusions of glucagon improve carbohydrate status in lactating dairy cows without increasing concentrations of plasma NEFA. The objective was to test whether single subcutaneous injections and multiple subcutaneous injections of glucagon delivered at 8-h intervals over 14 d improve the carbohydrate status in lactating dairy cows without increasing concentrations of plasma BHBA and NEFA. In a single-injection experiment, four midlactation cows each were injected with 2.5 and 5 mg of glucagon 1 wk apart. In a multiple-injection experiment, nine cows, assigned randomly to three treatments, were injected subcutaneously with 0, 2.5, or 5 mg of glucagon every 8 h for 14 d, beginning at d 8 postpartum. Single subcutaneous injections of glucagon increased concentrations of plasma glucagon and single and multiple subcutaneous injections of glucagon increased concentrations of plasma glucose, with larger increases at the 5-mg dosage. Injections of 5 mg of glucagon increased concentrations of plasma insulin in both experiments, whereas the 2.5-mg dosage increased plasma insulin only in the multiple-injection experiment. The response of glucose and insulin to injections of 5 mg of glucagon persisted throughout the 14-d injection period. Concentrations of plasma NEFA decreased in the single-injection experiment, and concentrations of BHBA decreased after 5 mg of glucagon was injected in the multiple-injection experiment. These results document that both single and multiple injections of 5 mg of glucagon over 14 d consistently improve the carbohydrate status of dairy cows and decrease concentrations of plasma NEFA and BHBA.

Relationship between serum TNF activity and insulin resistance in dairy cows affected with naturally occurring fatty liver

To clarity the relationship between tumor necrosis factor (TNF) and insulin resistance in dairy cows affected with fatty liver, naturally occurring cases were investigated. The affected cows were classified into following three groups according to histopathologic findings of the liver: mild fat droplet deposition (group 1; n=11), severe fat droplet deposition (group 2; n=10), and cloudy swelling (group 3; n=8). Serum TNF activities in Group 2 (8.67 +/- 2.16 U/ml) and Group 3 (11.65 +/- 1.92 U/ml) were significantly higher than that in Group 1 (3.57 +/- 0.81 U/ml) (p<0.05). The insulin-tolerance tests showed that the insulin-stimulated glucose disposal rates (GDR) in Group 2 (27.6 +/- 7.8%) and Group 3 (15.8 +/- 9.1%) were significantly lower than that in Group 1 (41.7 +/- 9.8%). There was a significant negative correlation between serum TNF activity and GDR in affected cows (r=-0.56, p<0.01). These results indicate that serum TNF activity is correlated with insulin resistance in cows with fatty liver.

Glucagon as a potential therapy for ketosis and fatty liver

An experiment demonstrating the usefulness of glucagon as a treatment for fatty liver and ketosis in early-lactation dairy cows has been described. This is the first report of the ability of glucagon, or any agent, to promote clearance of lipid from livers of animals suffering hepatic lipidosis. The development and use of glucagon as a therapeutic agent for the fatty-liver complex in dairy cows may provide a powerful management tool to enhance the profitability of the high-producing dairy cow.

Insulin resistance: the link between metabolic disorders and cystic ovarian disease in high yielding dairy cows?

A preliminary investigation was performed to examine whether insulin resistance is a factor in the pathogenesis of cystic ovarian disease (COD) in high-yielding dairy cows. In total 30 cows, of which 15 were diagnosed as suffering from COD based on the anamnesis and clinical examination, and the other 15 served as matched controls, were subjected to an intravenous glucose tolerance test (IVGTT). The aim of the study was to investigate whether insulin activity was altered in COD cows. Differences in glucose clearance between the COD cows and their controls were analyzed comparing the fractional turnover rate (k), the glucose half-time (T1/2), and the area under the curve (AUC) 60 and 120 min after infusion. Differences in insulin response were analyzed comparing the insulin increment, the insulin peak concentration, and the AUC 60 and 120 min after glucose infusion. Although insulin resistance, attended by a secondary hyperinsulinemia, is stated to directly contribute to the ovarian abnormalities that characterize the polycystic ovary syndrome (PCOS) in human medicine, this was not observed in COD cows. On the contrary, COD cows appeared to have a low insulin response following an intravenous glucose load as compared with their matched controls. This was illustrated by significantly lower insulin increments (P = 0.04) and lower insulin peak concentrations (P = 0.04). As COD cows had a significantly lower insulin response to a standard glucose load, it was concluded that insulin could be a factor in the pathogenesis of COD in dairy cows.

Metabolic responses of dairy cows and heifers to various intravenous dosages of glucagon

To evaluate the ability of glucagon to improve carbohydrate status in dairy cows without an increase in blood lipids, glucagon was infused intravenously for 48 h into lactating cows and spayed heifers in three crossover experiments. During Experiment 1, glucagon (5 and 20 mg/d) was infused into four midlactation cows. Experiment 2 involved the infusion of 0, 2.5, 5.0, or 10 mg/d of glucagon into eight heifers; each heifer received two of the dosages. In Experiment 3, four early lactation cows were treated with 5 and 10 mg/d of glucagon. Glucagon consistently increased plasma glucose concentrations in a dose-dependent fashion throughout the 48-h periods. Plasma insulin was increased in a nondose-dependent manner by glucagon in Experiment 1. Plasma urea N was increased when glucagon was administered at 5 mg/d during Experiment 2 and tended to be decreased during Experiment 3. Nonesterified fatty acids in plasma were, in most cases, not affected; however, they were increased by glucagon at 10 mg/d during Experiment 2. Concentrations of beta-hydroxybutyrate were increased only by the 20-mg/d dosage. During Experiment 1, liver glycogen concentrations decreased by 2.1% (wet weight basis) for both dosages of glucagon, and concentrations of total lipid in the liver were increased by 0.6% (wet weight basis) by 20 mg/d of glucagon. Milk fat percentage was increased by glucagon, but milk volume and milk protein production were decreased during Experiment 1. Glucagon improved carbohydrate status over the 48-h periods in all experiments but did not increase plasma nonesterified fatty acids except at the 10-mg/d dosage in Experiment 2.

Alleviation of fatty liver in dairy cows with 14-day intravenous infusions of glucagon

Twenty multiparous cows were fed additional concentrate during the final 30 d prepartum to cause susceptibility to fatty liver. From 14 to 42 d postpartum, all cows were subjected to a protocol to induce fatty liver and ketosis. To test glucagon as a treatment for fatty liver, either glucagon at 10 mg/d or excipient was infused via the jugular vein from 21 to 35 d postpartum. All cows had fatty liver at 14 d postpartum and became ketonemic and hypoglycemic during the induction of ketosis. Glucagon increased plasma glucose to 142% of that of controls throughout the 14-d treatment. The hypoinsulinemia present in cows with fatty liver was not affected by glucagon. Plasma beta-hydroxybutyrate and nonesterified fatty acids were decreased by glucagon. At 6 d postpartum, liver triacylglycerol averaged 12.9% of liver (wet weight basis). Glucagon had decreased triacylglycerol content of livers by 71% at d 35. Glycogen was 1.0% of the wet weight of livers at 6 d in milk, but it was decreased by glucagon to 0.5% at 2 d after glucagon began. Glycogen then increased in cows treated with glucagon until at 38 d in milk liver glycogen was 3.7% versus 1.6% in controls. Our results document that glucagon decreases the degree of fatty liver in early lactation dairy cows, which also decreases the incidence of ketosis after alleviation of fatty liver.

Metabolic responses of lactating dairy cows to 14-day intravenous infusions of glucagon

Twenty cows were assigned at parturition to two groups to study metabolic effects of continuous intravenous infusions of glucagon. Groups were control cows and cows treated with glucagon at 10 mg/d for 14 d starting at d 21 postpartum. Daily blood samples and nine liver biopsies were taken from d 7 to 49 postpartum. Plasma glucagon increased six- to seven-fold during infusions of treated cows. Plasma insulin was increased heterogeneously by glucagon infusions. Plasma glucose increased 11.5 and 9.0 mg/dl during wk 1 and 2 of glucagon infusions. No other plasma metabolites tested (nonesterified fatty acids, beta-hydroxybutyrate, and urea N) were affected by glucagon infusions. Liver glycogen decreased by d 2 of glucagon infusion but was repleted to preinfusion values by d 7 and increased to 169% of the preinfusion baseline values at 3 d after cessation of glucagon. Milk production decreased transiently during glucagon infusions. Both milk production and milk protein percentage decreased during glucagon infusion, which could imply a decreased availability of amino acids for milk protein synthesis. Feed intakes did not increase during glucagon infusions, which was in contrast to the control group. Results indicated that glucagon infusions caused liver glycogenolysis initially and probably enhanced gluconeogenesis but glucagon did not appear to increase lipolysis from adipose tissue in these early lactating dairy cows.

Dry cow diet, management, and energy balance as risk factors for displaced abomasum in high producing dairy herds

The objective of this study was to determine prepartum risk factors for displaced abomasum. The design was a prospective study of 1170 multiparous Holstein cows from 67 high producing dairy herds in Michigan. Each farm was visited four times within a 6-wk period. At each visit, data on nutrition and management were collected. All multiparous cows within 35 d of projected calving were assigned a body condition score, and blood was sampled to determine the concentration of nonesterified fatty acids in plasma. A multivariable linear regression model was used to determine risk factors associated with the incidence of displaced abomasum during lactation on a herd basis. A multivariable logistic regression model with random effect was used to determine risk factors for displaced abomasum on an individual cow basis. Significant risk factors for displaced abomasum included a negative energy balance prepartum (as estimated from plasma nonesterified fatty acids), a high body condition score, suboptimal feed bunk management prepartum, prepartum diets containing > 1.65 Mcal of net energy for lactation/kg of dry matter, winter and summer seasons, high genetic merit, and low parity.

Glucose and insulin responses to glucagon injection in dairy cows with ketosis and fatty liver

The purpose of this investigation was to study the metabolic situation in clinical cases of bovine ketosis and to diagnose additional diseases. Extensive clinical examination, clinical biochemistry, haematology and fine-needle aspiration biopsy of liver was performed on 17 ketotic and eight control dairy cows in the field, and on seven hospitalized hyperketonaemic fatty liver patients. Additional findings in the ketotic group were heat (n = 7), indigestion (n = 5), endometritis (n = 2), cystic ovaries (n = 1), and mastitis (n = 1), and in the fatty liver group displaced abomasum (n = 4), abomasal ulcers (n = 3), mastitis (n = 2), laminitis (n = 1), bronchopneumonia (n = 1), and hypomagnesaemia (n = 2). There were no additional findings in the control group. Aspartate aminotransferase (AST) and creatine kinase (CK) were elevated in the ketosis and fatty liver groups. Total bilirubin, gamma-glutamyl transferase (GGT) and glutamate dehydrogenase (GD) were elevated in the fatty liver group and in some animals in the ketosis group. Total bile acid was not different between the groups. The free fatty acid/cholesterol ratio was higher in the fatty liver group compared with the control and ketosis groups. There was no or only slight fatty degeneration of the liver cells in the control and ketosis groups. Glucose and insulin preinjection concentrations and changes from basal values after glucagon injection were significantly lower in the ketosis group if compared with the control group. The responses in the fatty liver animals after glucagon injection were more heterogeneous than in the control and ketosis animals, a sign of disturbance in the metabolic adaptation, which together with high free fatty acid (FFA) levels can lead to fatty liver in cows with concurrent diseases.

Plasma and liver alpha-tocopherol in dairy cows with left abomasal displacement and fatty liver

Thirty dairy cows with left abomasal displacement (LAD) and 14 healthy control cows were studied to assess the status of the natural antioxidant vitamin E, lipid peroxidation in the liver (malondialdehyde-formation) and its relationship to hepatic lipidosis. Blood concentrations of alpha-tocopherol, aminotransferase, glutamin dehydrogenase, free fatty acids, beta-hydroxybutyrate and glucose were determined. alpha-tocopherol, tryglyceride, glycogen and malondialdehyde (MDA) in wer liver tissue samples were examined. The dietary alpha-tocopherol intake and its plasma changes in LDA cows were also investigated. Cows were divided into four groups according to their liver triglyceride contents (< 20; 20-80; > 80 mg/g of fresh tissue; and control groups). The lowest plasma vitamin E and the highest liver vitamin E levels were found in cows with highest hepatic triglyceride content. The highest increase in plasma alpha-tocopherol within 5 days was seen in cows with the lowest liver triglyceride (P < 0.01). The liver triglyceride was positively correlated with liver MDA (r = 0.38; P < 0.05) and negatively with plasma alpha-tocopherol (r = -0.41; P < 0.01).

Effects of different energy levels, concentrate/forage ratios and lipid supplementation to the diet on the adaptation of the energy metabolism at calving in dairy cows

A low level of energy (110 MJ ME) and a low concentrate/forage ratio (10/90) at calving resulted in low basal concentrations of glucose and insulin, but the cows had the capacity to increase the glucose level after glucagon injections. No signs of disturbances in the metabolic adaptation were observed. High intensity feeding (200 MJ ME and 50% concentrates) resulted in high basal serum insulin levels. The increase in the insulin concentrations after glucagon injections and the changes in insulin levels around calving varied widely between individual cows. The metabolic adaptation period was longer than in cows in the former group. An energy level of 170 MJ ME and variations of concentrate/forage ratios (5/95, 30/70 and 60/40) resulted in small differences in basal glucose and insulin concentrations and in response to glucagon injections. But the cows fed 60% concentrates showed signs of prolonged metabolic adaptation. Increased lipid concentrations in diets containing equal levels of energy and protein resulted in a fall in basal glucose and insulin levels and the metabolism seemed to be directed towards catabolism. Because of these metabolic effects, more needs to be known on fat supplementation if it is used in practical feeding. It is also necessary to take more interest in the effects of protein feeding on the periparturient metabolism.

Abomasal displacement in the bovine--a review on character, occurrence, aetiology and pathogenesis

Literature on the subject of character, history, occurrence, causes and pathogenesis of abomasal displacement in the bovine is listed and summarized. The chapter on occurrence is subdivided according to heritibility, sex, age, season, husbandry, milk yield and concomitant diseases. In the chapter on causes special consideration is given to feeding. The chapter on pathogenesis is subdivided according to mechanical influences, disturbances of the abomasal motor activity, collection of gas and dilatation of the abomasum and artificial displacement of the abomasum. Displacement of the abomasum is seen predominantly in the spring in herds with above-average milk yield in dairy cows between the age of 4 and 7 years which have calved within the last month and have ketosis. The etiology and pathogenesis of abomasal displacement are unclear.

Periparturient concentrations of insulin glucagon and ketone bodies in dairy cows fed two different levels of nutrition and varying concentrate/roughage ratios

High producing multiparous dairy cows were fed either diets differing in energy content or diets with identical energy and protein content but differing in roughage content at the end of the dry period and beginning of lactation. Basal insulin and ketone bodies were analysed every week from 3 weeks before to 7 weeks after calving. Pancreatic glucagon was estimated 3 weeks before, 1-3 days after, and 3 weeks after calving. Before calving the feeding regimen had a very strong influence on the basal insulin level. High amounts of concentrate increased basal insulin levels until one week before calving and caused an interruption in the physiological decreasing course. After calving the insulin levels were low in all groups of cows. Before calving there were small variations in the glucagon levels, and no influence of feeding was observed. After calving there was a strong increase, especially in the cows fed the highest amounts of concentrate. Feeding high amounts of concentrate resulted in varying and in many cases increased levels of ketone bodies in plasma. Hyperketonemic cows had lower insulin and higher glucagon levels than normal cows. The influence of non-structural carbohydrates in the feed on pancreatic hormones is a cause of ketogenesis is discussed.

Acute metabolic effects of clenbuterol in calves

The acute metabolic effects of clenbuterol were studied in calves. Clenbuterol was given intravenously at a dose of 1 microgram/kg body weight. Glucagon was used to increase insulin secretion. Pretreatment with clenbuterol did not change the glucagon-induced hyperglycaemia, but the serum levels of insulin were significantly higher. Clenbuterol showed a significant lipolytic effect. The post prandial increases in glucose and insulin were significantly higher in clenbuterol treated calves. The findings are in accordance with results from earlier studies where clenbuterol was given orally in much higher doses.